Hysterectomy ends uterine pregnancy
The decision is permanent; fertility goals and uterus-preserving alternatives should be discussed before consent when clinically relevant.
Hysterectomy cost in Turkey
A responsible quotation states why the uterus is being removed, whether malignancy has been excluded or needs staging, total or supracervical extent, removal or preservation of tubes and ovaries, vaginal, laparoscopic, robotic, or open route, uterus size and adhesions, endometriosis or prolapse work, pathology, expected admission, menopause counseling, clot prevention, and recovery support.
How much does hysterectomy cost in Turkey?
A benign vaginal or laparoscopic hysterectomy in Turkey is commonly budgeted at TRY 188,000 to 470,000 (about USD 4,000 to 10,000). Robotic, large-uterus, severe endometriosis, prolapse-repair, or complex open surgery may require TRY 329,000 to 705,000 (about USD 7,000 to 15,000), while radical cancer surgery with staging can reach TRY 470,000 to 846,000 or more (about USD 10,000 to 18,000+).
USD examples use approximately TRY 47 per USD, close to the official indicative selling rate on 17 July 2026. Robotic disposables, pathology and molecular work, mesh or other implants, and cancer staging should be priced separately where relevant.
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Reviewed 2026-07-19
Clinical review: Virello Health Clinical Content Team · Editorial review: Virello Health Research Team
Billing context: TRY and USD
The decision is permanent; fertility goals and uterus-preserving alternatives should be discussed before consent when clinically relevant.
Removing normal ovaries can cause surgical menopause before natural menopause and should not be assumed merely because the uterus is removed.
Total and supracervical operations remove different anatomy, and cervical screening advice depends on history and what remains.
Preoperative biopsy, imaging, cervical screening, and specialist review reduce the risk of performing an inadequate benign operation for malignancy.
Cost at a glance
The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.
| Scenario | TRY | USD | Patient and treatment context | Planning scope |
|---|---|---|---|---|
| Benign vaginal or laparoscopic surgery | TRY 188,000 - 470,000 | USD 4,000 - 10,000 | Fibroids, bleeding, adenomyosis, pain, or prolapse treated by a defined minimally invasive or vaginal route after reasonable alternatives are reviewed. | Name total or supracervical extent, tubes and ovaries, surgeon, anesthesia, theatre, pathology, stated room days, routine medicines, clot plan, and early follow-up. |
| Complex benign or robotic pathway | TRY 329,000 - 705,000 | USD 7,000 - 15,000 | Large uterus, severe endometriosis, dense adhesions, previous operations, prolapse repair, urinary procedure, robotic access, or higher medical complexity. | Itemize added dissection, repair, robot, ureter or bladder evaluation, implant if any, blood allowance, conversion, and extended stay. |
| Radical or cancer-staging surgery | TRY 470,000 - 846,000+ | USD 10,000 - 18,000+ | Confirmed or strongly suspected gynecologic cancer requiring radical removal, nodes, omentum, staging, and specialist oncology pathology. | Requires a gynecologic-oncology plan and must separate staging, frozen section, nodes, pathology, ICU, complications, and possible chemotherapy or radiation. |
Usually included
Total or supracervical hysterectomy, approach, and the planned treatment of tubes, ovaries, cervix, and additional pelvic disease.
Consent and invoice should agree.
Surgeon, anesthesia, theatre, standard instruments, medicines, urinary catheter, room, and specified days.
Robotic and implant charges may be separate.
Routine examination of uterus, cervix, tubes, ovaries, or other submitted tissue.
Frozen section and oncology molecular tests may be extra.
Wound or vaginal-cuff assessment, medicine and bowel plan, activity guidance, pathology discussion, and travel review.
Ask about remote results if pathology is delayed.
Confirm separately
Endometriosis excision, myomectomy, prolapse repair, sling, ureteric stent, bowel or bladder repair, lymph nodes, and omentectomy unless named.
Price multidisciplinary involvement.
Platform, disposable instruments, vessel-sealing devices, cystoscopy, stents, mesh, or other implants.
Require an indication and product details.
Open conversion, transfusion, urinary or bowel injury, infection, clot, reoperation, ICU, or readmission.
Obtain rates before surgery.
Chemotherapy, radiation, hormone or menopause support, pelvic-floor therapy, and long-term surveillance.
A surgery package is not complete cancer care.
Candidate context
Hysterectomy may be considered for persistent heavy bleeding, fibroids, adenomyosis, uterine prolapse, selected endometriosis or pain, precancer, or cancer when less definitive treatment is unsuitable, unsuccessful, or not desired. Review should confirm diagnosis, blood loss and anemia, uterine and ovarian imaging, endometrial or cervical pathology where indicated, pregnancy and fertility goals, prior surgery, pelvic-floor and urinary symptoms, cancer risk, menopause priorities, and medical fitness.
Bleeding source, fibroid or adenomyosis burden, prolapse, pain cause, precancer, or malignancy should be defined before choosing route and extent.
Medicines, intrauterine treatment, ablation, myomectomy, uterine-artery treatment, prolapse support, or observation may fit selected patients.
Age, cancer and genetic risk, endometriosis, menopause, cervical history, and patient preference shape removal or preservation.
Anemia, anticoagulation, obesity, diabetes, smoking, sleep apnea, infection, stairs, caregiving, and clot risk affect planning.
Hormonal or nonhormonal medicines and an intrauterine system may reduce bleeding in selected benign conditions.
Myomectomy, hysteroscopic treatment, uterine-artery embolization, endometrial ablation, or prolapse repair may suit selected goals and diagnoses.
Prolapse symptoms may improve with physiotherapy, a pessary, lifestyle changes, or a repair that preserves the uterus.
Precancer or cancer should be reviewed by a specialist so operation, staging, pathology, and adjuvant treatment are adequate.
Procedure variations
Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.
The uterus is removed through the vagina, often for suitable prolapse or benign anatomy without abdominal incisions.
Additional pelvic-floor repair changes scope.
Keyhole instruments detach the uterus, which is removed through the vagina or another planned method.
Large tissue extraction must be discussed safely.
A larger incision may be needed for very large anatomy, extensive adhesions, cancer, bleeding, or another complex indication.
Stay and recovery are usually longer.
Cancer surgery removes wider tissue and may include nodes or other staging procedures.
Use a gynecologic oncologist.
City comparison
Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.
| City | Local range | USD range | Capability context | Stay planning |
|---|---|---|---|---|
| Istanbul | TRY 211,500 - 940,000+ | USD 4,500 - 20,000+ | Broad minimally invasive, robotic, endometriosis, pelvic-floor, and gynecologic-oncology access. | Complex and cancer surgery need specialist matching. |
| Ankara | TRY 188,000 - 846,000+ | USD 4,000 - 18,000+ | Strong university, public, and private gynecology services. | Confirm international access and oncology pathology. |
| Izmir | TRY 188,000 - 752,000+ | USD 4,000 - 16,000+ | Selected tertiary centers provide benign and oncology pathways. | Verify robotic and multidisciplinary availability. |
| Antalya | TRY 211,500 - 799,000+ | USD 4,500 - 17,000+ | International coordination supports standard minimally invasive care. | Separate hotel from postoperative clinical review. |
| Bursa | TRY 164,500 - 658,000+ | USD 3,500 - 14,000+ | Potential value for defined benign surgery. | Confirm pathology and complication rescue. |
| Kocaeli and Gebze | TRY 188,000 - 705,000+ | USD 4,000 - 15,000+ | Marmara tertiary access can support combined pelvic care. | Map any off-site oncology service. |
| Adana | TRY 164,500 - 611,000+ | USD 3,500 - 13,000+ | Regional centers provide standard gynecology surgery. | Confirm advanced endometriosis or cancer expertise. |
| Konya | TRY 141,000 - 564,000+ | USD 3,000 - 12,000+ | Selected hospitals may suit uncomplicated benign cases. | Check blood bank and urinary injury support. |
| Kayseri | TRY 141,000 - 564,000+ | USD 3,000 - 12,000+ | Tertiary gynecology review is available for selected pathways. | Plan pathology review before flying. |
| Gaziantep | TRY 141,000 - 517,000+ | USD 3,000 - 11,000+ | Procedure-specific hospital verification is required. | A base quote may exclude tubes, ovaries, or added repair. |
Estimate variables
Benign bleeding, fibroids, prolapse, endometriosis, precancer, and cancer require different surgeons, pathology, and staging.
Resolve suspicious findings first.
Vaginal, laparoscopic, robotic, and open routes differ with size, access, adhesions, and equipment.
Conversion terms should be explicit.
Tubes, ovaries, endometriosis, prolapse, bladder, bowel, ureter, nodes, or omentum add expertise and time.
List every planned procedure.
Biopsy review, frozen section, oncology pathology, nodes, imaging, and molecular work can change the total.
Cancer surgery needs specialist planning.
Anemia, obesity, previous operations, anticoagulation, diabetes, sleep apnea, and home support affect blood, stay, and recovery.
Optimize before travel.
Medical cost breakdown
Blood count, pelvic ultrasound, cervical screening, pregnancy testing, and endometrial biopsy or hysteroscopy when indicated.
Send full pathology.
MRI, CT, or specialist ultrasound for deep endometriosis, large masses, malignancy, urinary, or bowel involvement.
Use DICOM source files.
Heart, lung, glucose, anticoagulation, anemia, blood type, clot, and infection review.
Correct severe anemia before elective care.
Surgeon, anesthesia, theatre, named approach and extent, routine instruments, room, medicines, catheter, and standard pathology.
Added procedures require itemization.
Pain and nausea care, walking, clot prevention, bowel and bladder assessment, blood tests, wound or cuff review, and discharge.
Ask for extra-day rates.
Transfusion, open conversion, urinary or bowel procedure, infection, clot, reoperation, or ICU.
Clarify financial authorization.
Dressings, bleeding and discharge guidance, activity and lifting limits, pelvic-floor support, and scheduled review.
Follow the surgeon’s internal-healing timeline.
Constipation prevention, urinary assessment, multimodal pain medicine, mobility, hydration, and nutrition.
Retention or severe pain needs review.
Ovary-related hormone discussion, bone and heart health, final pathology, cervical guidance, and oncology referral if needed.
Do not leave before a results plan exists.
Complete journey budget
Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.
Elevator, bathroom access, companion, meals, short hospital transport, and room for gentle walking.
Avoid heavy luggage.
Flight changes, wheelchair support, clot strategy, pain and bowel medicines, and clinician-approved timing.
Open surgery may need longer.
Delayed results, extra nights, urinary review, transfusion, infection, wound care, or oncology consultation can add cost.
Keep emergency funds.
Country access
Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.
Confirm the exact Turkish hospital and campus responsible for surgery, pathology, blood, complication care, and follow-up.
The document should state uterus, cervix, tubes, ovaries, suspected disease, extraction method, added procedures, and conversion.
Ask about specimen identification, report language, slide or block release, unexpected malignancy review, and communication after departure.
Clinical treatment, hotel, transport, translation, and intermediary charges need distinct contracts and cancellation terms.
Check Turkish government entry information and allow for pathology, wound, or complication-related delay.
Hospital selection
Benign minimally invasive, endometriosis, pelvic-floor, or gynecologic-oncology expertise according to the actual indication.
One surgeon label does not cover every route.
Endometrial and cervical review, frozen section if planned, oncology expertise, specimen handling, report timing, and material release.
Unexpected findings need rapid escalation.
Urology, colorectal, interventional radiology, blood bank, infection, critical care, and urgent return-to-theatre access.
Important in complex adhesions and cancer.
Anemia, pain, nausea, clot, catheter, bowel, pelvic-floor, menopause, and home-handover support.
Ask who reviews the final pathology.
Conversion, transfusion, urinary or bowel injury, infection, clot, readmission, reoperation, pain, and function with definitions.
Reject guaranteed recovery claims.
Treating team
Confirms diagnosis, alternatives, approach, extent, cervix, tubes and ovaries, extraction, expected pathology, and recovery.
Leads suspicious or confirmed cancer surgery, staging, specialist pathology, and adjuvant treatment planning.
Optimizes anemia, blood, heart, lung, diabetes, anticoagulation, pain, nausea, and clot prevention.
Addresses urinary and bowel function, prolapse, sexual health, surgical menopause, mobility, and return to activity.
Treatment timeline
Send bleeding and pain history, imaging, biopsy, cervical screening, prior operations, fertility and menopause goals, health, and medicines.
Repeat examination, resolve cancer risk, correct anemia, select route and extent, and document organ and conversion decisions.
Perform the defined operation, record added findings and procedures, and send labeled tissue for appropriate examination.
Manage pain, nausea, blood, catheter, bowel, walking, clot prevention, wound or cuff, and discharge criteria.
Confirm result timing, wound and bleeding, bladder and bowel function, medicines, activity, and flight readiness.
Transfer operation and pathology, organ status, menopause plan, restrictions, cervical advice, and oncology or routine follow-up.
Risks and edge cases
Large uterus, adhesions, endometriosis, cancer, anemia, or vessel injury can require blood, open conversion, or reoperation.
Ask about blood access.
Pelvic organs can be injured during difficult dissection and may need stent, repair, drainage, or another specialist.
Confirm rescue availability.
Fever, drainage, leg swelling, chest pain, breathlessness, or increasing pain needs prompt assessment.
Know the emergency route.
Final pathology may identify precancer or cancer and lead to imaging, another operation, chemotherapy, or radiation.
Plan specialist review before departure.
Ovary removal can trigger menopause, while bladder, bowel, sexual, pelvic-floor, or pain symptoms may persist or change.
Discuss realistic goals.
Destination comparison
The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.
| Decision factor | India | Turkey | Thailand | How to use this |
|---|---|---|---|---|
| Minimally invasive access | Broad laparoscopic and robotic city options with competitive pricing. | Strong private and academic services in major cities. | Leading private hospitals offer coordinated minimally invasive care. | Match surgeon to diagnosis, not robot brand. |
| Cancer and pathology depth | Major cancer centers provide staging and adjuvant care. | Tertiary Istanbul, Ankara, and selected centers integrate oncology. | Advanced oncology is concentrated in principal hubs. | Suspicion of cancer should drive destination. |
| Quote currency | Usually INR with USD illustrations. | TRY with possible foreign-currency robotic and implant charges. | THB with premium private-hospital pricing. | Compare complete surgical scope. |
| Recovery travel | May involve longer flights for European origins. | Convenient for Europe and nearby regions. | Regional access suits Asian patients. | Pathology and complication continuity matter. |
Decision guidance
A verified diagnosis-matched surgeon explains alternatives, names the approach and organs, provides pathology and rescue systems, and plans home continuity.
The quote does not state whether cervix, tubes or ovaries are removed, treats robotics as mandatory, omits pathology, or encourages immediate sightseeing.
Diagnosis, cancer risk, uterus-preserving options, ovary removal, radical extent, endometriosis or prolapse repair, or open conversion remains disputed.
There is heavy bleeding, fainting, fever, worsening abdominal pain, vomiting, inability to pass urine, calf swelling, chest pain, or breathlessness.
Reports for review
Send symptom and bleeding history, recent blood count, pelvic ultrasound and MRI or CT when performed, biopsy and cervical reports, prior pelvic operation notes, pregnancy and fertility history, urinary and bowel symptoms, family cancer and genetic information, medicines and allergies, menopause priorities, and current medical assessment.
Upload medical reportsProvide ultrasound and any MRI or CT source studies with dates.
Send endometrial biopsy, hysteroscopy, cervical cytology or biopsy, and prior specimen reports.
Describe bleeding, pain, pressure, prolapse, urinary, bowel, sexual, and anemia effects.
List medicines, devices, ablation, embolization, myomectomy, cesarean, endometriosis, and prolapse treatment.
Include anemia, heart, lung, diabetes, BMI, sleep apnea, clot, infection, and blood records.
List anticoagulants, hormones, steroids, supplements, and reactions.
State pregnancy wishes, ovary preferences, menopausal symptoms, and hormone concerns.
Include family history, genetic results, previous precancer, and specialist opinions.
Describe caregiver, stairs, bathroom, childcare, work, lifting, and local follow-up.
Add flight duration, stopovers, wheelchair need, companion, and intended stay.
Ask the surgeon to list approach, cervix, tubes, ovaries, extraction, and added procedures.
Confirm report timing, English copy, slide or block release, and unexpected-cancer contact.
Common questions
A benign vaginal or laparoscopic procedure is broadly TRY 188,000 to 470,000, around USD 4,000 to 10,000, with complex or cancer surgery costing more.
No. Ovary removal is a separate decision based on age, disease, cancer and genetic risk, endometriosis, menopause impact, and patient preference.
Total hysterectomy removes uterus and cervix; supracervical surgery leaves the cervix. Indication, screening history, route, and follow-up differ.
Not universally. Diagnosis, anatomy, uterus size, adhesions, surgeon expertise, total scope, conversion and complication systems matter more than the platform alone.
Sometimes. Medicines, intrauterine treatment, ablation, myomectomy, embolization, pessary, pelvic-floor treatment, or another repair may suit selected benign conditions.
Stay depends on route, blood, wound or cuff, bladder and bowel function, pain, walking, pathology plan, medical risk, and flight duration.
Removing the uterus stops periods and pregnancy, but immediate surgical menopause usually relates to removal or failure of both ovaries.
Routine pathology may be included, but frozen section, oncology review, molecular tests, node assessment, and slide consultation should be confirmed.
The surgeon should assess bleeding, wound, pain, walking, bladder and bowel function, clot risk, medicines, flight length, and possible pathology-related care.
Heavy bleeding, fainting, fever, worsening abdominal pain, persistent vomiting, inability to pass urine, calf swelling, chest pain, or breathlessness needs prompt assessment.
Review and sources
Ranges separate uncomplicated benign minimally invasive surgery, complex benign or robotic care, and radical oncology surgery. Turkey market signals were normalized near TRY 47 per USD and expanded for approach, organ extent, adhesions, endometriosis or prolapse work, pathology, blood, room, conversion, menopause, and recovery. NHS, NICE, and NCI sources inform patient decision structure; Turkish official sources support provider verification. Quotes require diagnosis and source records.
This guide is educational and cannot diagnose the condition, decide whether hysterectomy is necessary, select route or organ removal, exclude cancer, or clear travel. Use gynecologic review, indicated pathology and imaging, informed consent, and a current written quote. Heavy bleeding, fainting, fever, worsening abdominal pain, inability to pass urine, calf swelling, chest pain, or breathlessness requires urgent local care.
UK National Health Service · Accessed 2026-07-19
Supports: Reasons, types, alternatives, and recovery context.
National Institute for Health and Care Excellence · Accessed 2026-07-19
Supports: Assessment and uterus-preserving treatment principles.
US National Cancer Institute · Accessed 2026-07-19
Supports: Cancer-specific surgery and adjuvant context.
Republic of Turkey Ministry of Health · Accessed 2026-07-19
Supports: International-patient framework.
Republic of Turkey Ministry of Health · Accessed 2026-07-19
Supports: Hospital-verification route.
Republic of Turkey Ministry of Health · Accessed 2026-07-19
Supports: Clinical-service oversight directory.
Central Bank of the Republic of Turkey via e-Government Gateway · Accessed 2026-07-19
Supports: TRY and USD conversion context.
Related planning
Understand fertility implications and alternatives.
Review another laparoscopic pathway with long follow-up.
Compare INR and USD planning.
Understand approaches, preparation, and recovery.
Review fertility treatment before definitive surgery.
Compare fertility and gynecology support.
Review specialist-selection questions.
Prepare imaging and pathology.
Coordinate pathology and recovery at home.
Request an approach- and organ-specific estimate.
Questions about an estimate? Email support@virellohealth.com.